Cancer’s Impact on Forensic Age Estimation Research
- Determining a person's age from biological samples is a crucial task in many legal investigations.
- Though, the accuracy of these methods can be challenged by underlying health conditions.A new study, published July 17, 2025, in Aging-US, investigates the influence of cancer on the...
- Researchers at the Zurich Institute of Forensic Medicine, University of Zurich, and onkozentrum Zurich, led by Charlotte Sutter, Daniel Helbling, Cordula Haas, and Jacqueline Neubauer, explored whether different...
Cancer’s subtle Impact on Forensic Age Estimation
Table of Contents
The Growing Field of Forensic Age Prediction
Determining a person’s age from biological samples is a crucial task in many legal investigations. Forensic scientists increasingly rely on DNA methylation – naturally occurring chemical changes to DNA that accumulate with age – to estimate age with increasing accuracy. This technique is particularly valuable when conventional methods, like skeletal analysis, are unavailable or inconclusive.
Though, the accuracy of these methods can be challenged by underlying health conditions.A new study, published July 17, 2025, in Aging-US, investigates the influence of cancer on the reliability of forensic age estimation tools.
How Cancer Alters the Biological Clock
Researchers at the Zurich Institute of Forensic Medicine, University of Zurich, and onkozentrum Zurich, led by Charlotte Sutter, Daniel Helbling, Cordula Haas, and Jacqueline Neubauer, explored whether different cancer types could skew age predictions based on DNA methylation patterns. Cancer is known to disrupt normal cellular processes, and these disruptions can potentially affect the epigenetic markers used in forensic analysis.
The study focused on the VISAGE enhanced age estimation tool, a widely used method for predicting age from DNA methylation data. The team analyzed blood samples from 100 cancer patients and 102 healthy individuals to compare age predictions between the two groups.
Key Findings: A Nuanced Picture
The results revealed a complex relationship between cancer and age estimation accuracy. In the control group, age predictions were generally very accurate. Patients with solid tumors – such as breast and lung cancers – showed only a slight reduction in accuracy.However, individuals with blood cancers, specifically chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML), exhibited significantly larger errors, with age estimations sometimes being off by as much as 50 years.
Despite these outliers, the overall impact of cancer on the VISAGE tool’s accuracy was found to be relatively modest. Moast cancer patients, even those undergoing treatment, displayed DNA methylation patterns comparable to those of healthy individuals. The researchers observed no consistent differences in age estimation accuracy based on cancer type, stage, or treatment regimen, accept in cases involving particularly aggressive cancers.
Implications for Forensic science
These findings reinforce the continued validity of current forensic age estimation methods. While aggressive cancers can occasionally lead to inaccurate predictions, such instances appear to be rare. The researchers suggest that clinicians and forensic scientists should be aware of a patient’s cancer status and consider it as a potential factor when encountering unusually large discrepancies in age estimations.
This research provides valuable insight into the interplay between health conditions and forensic science. It strengthens confidence in the reliability of DNA-based age prediction tools,even when applied to individuals with a history of cancer.